The IRROG Team at Cancer Trials Cork is based at Cork University Hospital
The IRROG Team at Cancer Trials Cork is based at Cork University Hospital. Cancer Trials Cork (formerly known as the Oncology Clinical Trials Unit) was established in 2003 in Cork University Hospital, with the addition of radiotherapy clinical trials in 2012. In 2019, we relocated our headquarters within CUH to the newly constructed, state of the art, Glandore Radiotherapy Centre at Cork University Hospital, where we have dedicated clinical trials clinics and offices. Cork University Hospital was also recently awarded accreditation from the Organisation of European Cancer Institutes (OECI), highlighting its commitment to excellence in cancer care and research.
"We are offering practice changing clinical trials"
Professor Aisliing Barry, CUH UCC site lead.
Cancer Trials Cork
Cancer Trials Cork has a broad Clinical trial portfolio serving a geographically diverse population of 1.2 million in the South of Ireland. Specifically Cancer Trials Cork’s Radiotherapy clinical trials conducts late-phase trials, across a broad range of disease portfolios.
An integral part of the Irish Research Radiation Oncology Group
As an integral part of the Irish Research Radiation Oncology Group, Cancer Trials Cork collaborates with partner centres nationwide to deliver high-quality, patient-centred clinical trials. Our multidisciplinary team includes six Principal Investigators, one Research Nurse, one Data Manager, two Radiation Therapists & Admin support, bringing together extensive clinical and research expertise to ensure the rigorous conduct of complex radiotherapy studies.
Tailored trial management services
Supported by advanced radiotherapy technology and comprehensive clinical facilities, we offer tailored trial management services designed to meet the needs of investigators, sponsors, and patients. Patient safety, ethical standards, and transparent communication are our highest priorities, fostering informed consent and compassionate care throughout every stage of the research process.
Innovation that improves treatments and outcomes for patients living with cancer
Through active participation in this national collaborative network, Cancer Trials Cork plays a leading role in advancing radiotherapy research across Ireland. By integrating local expertise with shared knowledge and resources, we contribute to innovation that improves treatments and outcomes for patients living with cancer.
Meet the Team
Professor Aisling Barry
Professor Aisling Barry
Professor Aisling Barry is the Site Lead for IRROG at Cork University Hospital (CUH) and holds the pioneering post of Professor and Chair of Radiation Oncology at University College Cork (UCC). She brings a unique blend of international clinical experience, academic leadership, and translational research expertise to the IRROG network.
Professor Barry previously served as a Radiation Oncologist at the Princess Margaret Cancer Centre (PMCC) in Toronto and as Assistant Professor at the University of Toronto, where she was Clinical Lead of the Palliative and Oligo-metastatic Radiation Programme. Her clinical specialties include breast, gastrointestinal, and liver and lung oligo-metastatic cancers, with a strong focus on stereotactic body radiotherapy (SBRT).
She is a graduate of Trinity College Dublin and completed specialist training via the RCSI/St. Luke’s Radiation Oncology Network. Her post-specialist fellowships in breast cancer radiotherapy and SBRT were completed at PMCC, alongside a Master’s in Clinical Epidemiology that focused on quality-of-life outcomes in cancer patients.
Professor Barry is widely recognised for her academic excellence and is the recipient of numerous awards, including the Dr. Richard Steevens’ HSE Fellowship Award, the ASCO Merit Award for her work in liver cancer, and the Lynn Sage Breast Cancer Symposium Award. Her current research integrates cutting-edge radiotherapy with patient-reported outcomes and personalised treatment strategies, and she continues to lead Irish participation in international collaborative trials.
Ella O Sullivan
Murtaza Gangardiwala
Debra O’Hare
Elaine Cronin
Ali Noureldein
Professor Roisin Connolly
Mary Glass
Justin Dennehy